Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Scalp micropigmentation, a cosmetic tattoo technique, is a promising non-surgical treatment for hair and scalp deformities, despite potential complications.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Herbal treatments can help with early-stage BPH symptoms, but more research is needed.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Vitamin A toxicity can cause severe health issues and may require a liver transplant if other treatments fail.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Skin and nail problems like hair loss, dry skin, and fungal infections are common in people with long-term Type 2 Diabetes and can be prevented with good blood sugar control and foot care.

Some young Angus cattle had skin problems due to not enough vitamin A, which got better after they were given more vitamin A.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.